Home » Newsletters » BioWorld Asia

BioWorld Asia

July 21, 1999

View Archived Issues

Commission, Member States In New Clashes Over GMOs

New Gene Therapy Method Appears To Trigger Apoptosis

Proneuron Plans to Start Trials Of Macrophage CNS Therapy

Australians Use tRNA In New Approach To Gene Expression

Swiss Company Sulzer Medica Creating Biotech Division In U.S.

SR Pharma's Adjuvant Appears Beneficial In Phase II Trial

SmithKline Starts Phase IIb For Cantab's Warts Vaccine

France, Luxembourg Accused Of Violating EU Biotech Rules

Committee Recommends Against Genetic Testing In The Workplace

Gemini Licenses Osteoporosis Gene For Use By Affymetrix

Phytopharm Licenses Rights To Hepatitis B Compound

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.